NCT07470112

Brief Summary

The local application of gentamicin-containing collagen implants reduces the incidence of surgical site infections in high-risk cardiac surgery patients compared to standard prophylactic measures alone.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
142

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

February 26, 2026

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 13, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

10 months

First QC Date

February 26, 2026

Last Update Submit

March 12, 2026

Conditions

Keywords

Poststernotomy,Surgical Site Infection (SSI)local gentamycin containig collagen

Outcome Measures

Primary Outcomes (5)

  • Rate of infection severity (superficial and deep infections)

    during first 3 months post operative

  • Incidence of adverse effects of gentamicin implants

    during first 3 months post operative

  • Length of hospital stay

    during first 3 months post operative

  • short-term surgical outcome checklist

    Reduce mediastinits and improve sternum healing in relation to different types of of sternum closure.

    during first 3 months post operative

  • assess degree of healing

    non contrast C.T.chest done to assess degree of healing by The 6-Point CT Score (Stacy Score): 0 Non-union No evidence of bone bridging; wide gap. 1. Minimal union Rare/slight bone bridging across the osteotomy. 2. Mild union Less than 25% bone bridging. 3. Moderate union 25% to 50% bone bridging. 4. Near-complete More than 50% bone bridging with high stability. 5. Complete union Sternal halves well-aligned; no perceptible gap; looks like normal bone.

    after 3 months non contrast C.T.chest done to assess degree of healing by the Six Points Scale

Study Arms (2)

gentamycin

EXPERIMENTAL

Patients in this group had local sternal Gentamycin containing collagen between two edges of the sternum

Procedure: Gentamycin

control

ACTIVE COMPARATOR

Patients in this group sternum will be closed without application of local Gentamycin containing collagen

Procedure: bone wax

Interventions

GentamycinPROCEDURE

Patients in this group had local sternal Gentamycin containing collagen between two edges of the sternum.

gentamycin
bone waxPROCEDURE

Patients in this group sternum will be closed without application of local Gentamycin containing collagen.

control

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Uncontrolled hypertension and diabetes mellitus patients.
  • Obesity (BMI\>30 kg/m2).
  • Female gender.
  • Osteoporosis of the sternum.
  • Chronic Obstructive Pulmonary Disease (COPD).
  • Steroid therapy or immunosuppression.
  • Intraoperative intra-aortic balloon pump (IABP) use.
  • Re-exploration for bleeding.
  • Long time of cardiopulmonary bypass (\>180 minutes).
  • Redo cardiac surgery operation (elective )

You may not qualify if:

  • o Patients with known allergies to gentamicin.
  • Patients less than 18 years old.
  • Off-pump cardiac surgery.
  • Minimal invasive cardiac surgery.
  • Elevated serum creatinine level.
  • Emergent cases
  • Harvesting of Bilateral internal thoracic artery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

cardiothorathic surgery department -faculty of medecine-zagazig univeristy- Egypt

Zagazig, Sharqia Province, 44519, Egypt

Location

MeSH Terms

Conditions

Surgical Wound Infection

Interventions

Gentamicinsbone wax

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AminoglycosidesGlycosidesCarbohydrates

Study Officials

  • amr tawfeek

    cardiothoracic surgery department-faculty of medecine-Zagazig univeristy-Egypt

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Gentamycin Group: Patients in this group had local sternal Gentamycin containing collagen between two edges of the sternum. (Gentamycincontaining collagen will be applied to retrosternal and between both sternal halves similar to bone wax just prior to sternal wiring (T-SHAPED. )
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ass prof

Study Record Dates

First Submitted

February 26, 2026

First Posted

March 13, 2026

Study Start

May 20, 2025

Primary Completion

March 1, 2026

Study Completion

May 1, 2026

Last Updated

March 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

by publication of the study

Shared Documents
STUDY PROTOCOL
Time Frame
after publication of the study

Locations